Abstract:
PROBLEM TO BE SOLVED: To provide a pharmaceutical composition and method for use in inhibiting growth of cancer cells in a mammalian subject.SOLUTION: A composition includes a urease enzyme, and associated therewith, a chemical entity effective to enhance the delivery of the enzyme to cancer cells, when the composition is administered to a subject. Also disclosed are a method of enhancing the effectiveness of weakly basic anti-tumor compounds, a method assessing the presence, size or condition a solid tumor in the subject, and a gene therapy composition for treating a cancer in the subject.
Abstract:
PROBLEM TO BE SOLVED: To provide a pharmaceutical composition and a method for use in inhibiting growth of cancer cells in a mammalian subject.SOLUTION: The composition includes a urease enzyme, and associated therewith, a chemical entity effective to enhance the delivery of the enzyme to cancer cells, when the composition is administered to the subject. Also disclosed are a method for enhancing the effectiveness of weakly basic anti-tumor compounds, a method for assessing the presence, size or condition of a solid tumor in a subject, and a gene therapy composition for treating a cancer in a subject.
Abstract:
A protein interaction method and composition are described. The method and composition are useful for a number of purposes including: reconstituting multisubunit protein complexes, identifying known binding subunits, detrmining the kinetics and order of self assembly of a multsubunit protein complex, and drug screening. The method involves contacting a conjugate with a solid surface having an immobilized first coil-forming peptide characterized by a selected charge and an ability to interact with a second, oppositely carged coil-forming peptide to form a stable alpha-helical coiled-coil heterodimer, where the conjugate comprises (a) the second, oppositely charged coil-forming peptide, and (b) a first subunit polypeptide which is one of a plurality of subunit polypeptides in a multisubunit complex. By said contacting the conjugate is bound to the solid surface. Other subunit of the complex are added under conditions effective to promote self-assembly of the subunit complex or the solid surface.
Abstract:
A protein interaction method and composition are described. The method and composition are useful for a number of purposes including: reconstituting multisubunit protein complexes, identifying known binding subunits, detrmining the kinetics and order of self assembly of a multsubunit protein complex, and drug screening. The method involves contacting a conjugate with a solid surface having an immobilized first coil-forming peptide characterized by a selected charge and an ability to interact with a second, oppositely carged coil-forming peptide to form a stable α-helical coiled-coil heterodimer, where the conjugate comprises (a) the second, oppositely charged coil-forming peptide, and (b) a first subunit polypeptide which is one of a plurality of subunit polypeptides in a multisubunit complex. By said contacting the conjugate is bound to the solid surface. Other subunit of the complex are added under conditions effective to promote self-assembly of the subunit complex or the solid surface.
Abstract:
Methods and compositions to restore function to acidified T cells are provided. The methods comprise administering urease to the T cells. Compositions comprise urease.
Abstract:
A chimeric antigen receptor (CAR) that binds to CEACAM6, an epitope or fragment thereof, or a variant thereof is disclosed. The use of cells comprising said CAR in the treatment of CEACAM6+ cancers is also disclosed.
Abstract:
A pharmaceutical composition and method for use in inhibiting growth of cancer cells in a mammalian subject are disclosed. The composition includes a urease enzyme, and associated therewith, a chemical entity effective to enhance the delivery of the enzyme to cancer cells, when the composition is administered to the subject. Also disclosed are a method of enhancing the effectiveness of weakly basic anti-tumor compounds, a method assessing the presence, size or condition a solid tumor in a subject, and a gene therapy composition for treating a cancer in a subject.